|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
14,240,000 |
Market
Cap: |
99.68(M) |
Last
Volume: |
231,508 |
Avg
Vol: |
230,868 |
52
Week Range: |
$4.06 - $8.25 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 2.7 |
Insider 6 Months : 8.4 |
Insider 3/6 Months : 11.5 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Lifevantage engages in the identification, research, development, formulation and sale of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and other products. Co.'s line of dietary supplements includes its primary Protandim® family of products, LifeVantage® Omega+, ProBio, IC Bright®, and Daily Wellness dietary supplements. TrueScience® is Co.'s line of skin, hair, bath and body, and other products. Co. also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio®, its nootropic energy drink mixes, and PhysIQ, its weight management system.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
449 |
19,932 |
66,560 |
72,210 |
Total Buy Value |
$3,142 |
$96,554 |
$335,842 |
$358,711 |
Total People Bought |
1 |
2 |
5 |
5 |
Total Buy Transactions |
1 |
7 |
16 |
20 |
Total Shares Sold |
0 |
5,500 |
5,500 |
5,500 |
Total Sell Value |
$0 |
$33,000 |
$33,000 |
$33,000 |
Total People Sold |
0 |
1 |
1 |
1 |
Total Sell Transactions |
0 |
1 |
1 |
1 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fife Steven R |
President CEO and CFO |
|
2021-07-01 |
4 |
D |
$9.44 |
$22,684 |
D/D |
(2,403) |
155,614 |
|
- |
|
Fife Steven R |
President CEO and CFO |
|
2021-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,431 |
158,017 |
|
- |
|
Mcmurray Kevin |
General Counsel |
|
2021-01-01 |
4/A |
D |
$9.32 |
$9,609 |
D/D |
(1,031) |
49,725 |
|
- |
|
Mcmurray Kevin |
General Counsel |
|
2021-01-01 |
4/A |
OE |
$0.00 |
$0 |
D/D |
1,177 |
50,756 |
|
- |
|
Beindorff Michael A |
Director |
|
2021-01-01 |
4 |
D |
$9.32 |
$9,609 |
D/D |
(1,031) |
49,725 |
|
- |
|
Beindorff Michael A |
Director |
|
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,177 |
50,756 |
|
- |
|
Rose Justin |
Chief Sales &Marketing Officer |
|
2021-01-01 |
4 |
D |
$9.32 |
$11,995 |
D/D |
(1,287) |
153,447 |
|
- |
|
Rose Justin |
Chief Sales &Marketing Officer |
|
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,392 |
154,734 |
|
- |
|
Wach Charles J. |
Chief Operating Officer |
|
2021-01-01 |
4 |
D |
$9.32 |
$10,420 |
D/D |
(1,118) |
35,685 |
|
- |
|
Wach Charles J. |
Chief Operating Officer |
|
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,162 |
36,803 |
|
- |
|
Fife Steven R |
CFO and Interim CEO |
|
2021-01-01 |
4 |
D |
$9.32 |
$25,565 |
D/D |
(2,743) |
153,560 |
|
- |
|
Fife Steven R |
CFO and Interim CEO |
|
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,431 |
156,303 |
|
- |
|
Mcmurray Kevin |
General Counsel |
|
2020-12-05 |
4 |
D |
$11.00 |
$13,321 |
D/D |
(1,211) |
49,579 |
|
- |
|
Mcmurray Kevin |
General Counsel |
|
2020-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
966 |
50,790 |
|
- |
|
Rose Justin |
Chief Sales &Marketing Officer |
|
2020-12-05 |
4 |
D |
$11.00 |
$15,851 |
D/D |
(1,441) |
153,342 |
|
- |
|
Rose Justin |
Chief Sales &Marketing Officer |
|
2020-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,074 |
154,783 |
|
- |
|
Fife Steven R |
CFO and Interim CEO |
|
2020-12-05 |
4 |
D |
$11.00 |
$39,996 |
D/D |
(3,636) |
152,872 |
|
- |
|
Fife Steven R |
CFO and Interim CEO |
|
2020-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,291 |
156,508 |
|
- |
|
Wach Charles J. |
Chief Operating Officer |
|
2020-12-05 |
4 |
D |
$11.00 |
$13,794 |
D/D |
(1,254) |
35,641 |
|
- |
|
Wach Charles J. |
Chief Operating Officer |
|
2020-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
895 |
36,895 |
|
- |
|
Mauro Garry Paul |
Director |
|
2020-12-01 |
4 |
OE |
$5.60 |
$229,003 |
D/D |
31,429 |
173,513 |
|
- |
|
Brockovich Erin |
Director |
|
2020-11-12 |
4 |
A |
$11.15 |
$75,753 |
D/D |
6,794 |
15,347 |
|
- |
|
Greer Raymond B |
Director |
|
2020-11-12 |
4 |
A |
$11.15 |
$75,753 |
D/D |
6,794 |
51,873 |
|
- |
|
Hegde Vinayak |
Director |
|
2020-11-12 |
4 |
A |
$11.15 |
$75,753 |
D/D |
6,794 |
50,373 |
|
- |
|
Mauro Garry Paul |
Director |
|
2020-11-12 |
4 |
A |
$11.15 |
$75,753 |
D/D |
6,794 |
142,084 |
|
- |
|
524 Records found
|
|
Page 7 of 21 |
|
|